Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026)

Becton Dickinson (BDX) reported Cash from Financing Activities of -$414.0 million for Q1 2026, down 989.47% year-over-year from $46.5 million in Q1 2025, and down 37.09% quarter-over-quarter from -$302.0 million in Q4 2025.

Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Cash from Financing Activities data on file, last reported at -$414.0 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$414.0 million, down 989.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 billion (down 227.84% YoY), and the FY2025 annual result was -$3.6 billion, down 273.31% from the prior year.
  • Cash from Financing Activities declined to -$414.0 million in Q1 2026 per BDX's latest filing, from -$302.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $1.7 billion in Q1 2024 and troughed at -$1.9 billion in Q4 2024.
  • A 5-year average of -$271.2 million and a median of -$534.0 million in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities soared 427.57% in 2022, then plunged 989.47% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at -$534.0 million in 2022, then sank by 61.42% to -$862.0 million in 2023, then tumbled by 123.67% to -$1.9 billion in 2024, then soared by 84.34% to -$302.0 million in 2025, then slumped by 37.09% to -$414.0 million in 2026.
  • Business Quant data shows BDX's Cash from Financing Activities at -$414.0 million in Q1 2026, -$302.0 million in Q4 2025, and -$809.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn -230.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -414.00 Mn
Mar 31, 2026 -414.00 Mn
Dec 31, 2025 -302.00 Mn
Dec 31, 2025 -302.00 Mn
Sep 30, 2025 -809.00 Mn
Sep 30, 2025 -809.00 Mn
Jun 30, 2025 -842.00 Mn
Jun 30, 2025 -842.00 Mn
Mar 31, 2025 -38.00 Mn
Mar 31, 2025 -38.00 Mn
Dec 31, 2024 -1.93 Bn
Dec 31, 2024 -1.93 Bn
Sep 30, 2024 124.00 Mn
Sep 30, 2024 124.00 Mn
Jun 30, 2024 1.12 Bn
Jun 30, 2024 1.12 Bn
Mar 31, 2024 1.71 Bn
Mar 31, 2024 1.71 Bn
Dec 31, 2023 -862.00 Mn
Dec 31, 2023 -862.00 Mn